has an anti-inflammatory effect in the colon and is a suitable treatment for ulcerative colitis. Guiseppe Celasco and his colleagues did a double-blind, randomized, placebo-controlled phase IIa ...

This guideline groups the 12 currently available advanced treatments based on efficacy, to simplify the decision-making ...

The current recommendations of the American Dietetic Association (ADA), clinical practice guidelines from selected ... [2] Ulcerative Colitis The dietary information for patients with UC is ...

The American Gastroenterological Association (AGA) has released a new clinical guideline on the pharmacological management of ...

The American Gastroenterological Association (AGA) has released a new clinical guideline on the pharmacological management of moderate-to-severe ulcerative colitis, published today in Gastroenterology ...

Several informal sources of dietary information for patients with IBD exist through the Crohn's & Colitis Foundation of America, The National Digestive Diseases Information Clearinghouse and ...

5. The guidance recommends advanced or immunomodulatory therapy after failure of 5-aminosalicylates instead of a "step-up" approach. The recommendations also define moderate to severe disease using a ...

Treatment options for patients with corticosteroid-refractory ulcerative colitis are limited. Anti-CD3 monoclonal antibody treatment to inhibit activated T cells holds promise; however ...

The AGA has categorized drugs with similar efficacy into "efficacy buckets," allowing clinicians to break down effective treatments based on the likelihood of inducing remission. Treatment ...

Inflammatory Bowel Disease (IBD), encompassing ulcerative colitis (UC) and Crohn’s disease (CD), presents a unique clinical ...

An experimental monoclonal antibody treatment appears to ease the digestive disorder ulcerative colitis in patients who've ...